Skip to content

Low-Level Laser Therapy and Voice Training for Singers with Voice Disorders

Photobiomodulation Associated with Voice Therapy in Singers with Vocal Symptoms: A Randomized Clinical Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-2zs6bbz
Enrollment
64
Registered
2026-07-09
Start date
2026-06-02
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dysphonia Voice Disorders

Interventions

This study is a randomized controlled clinical trial with two parallel arms and a double-blind design. After providing written informed consent, eligible participants will be randomly allocated into t

Sponsors

Universidade Federal de Pernambuco
Lead Sponsor
Universidade Federal de Pernambuco
Collaborator

Eligibility

Age
18 Years to 59 Years

Inclusion criteria

Inclusion criteria: Amateur singers of both sexes. Age between 18 and 59 years. Score greater than 16 on the Voice Symptom Scale. Score greater than 23 on the Singing Voice Handicap Index. Normal laryngeal structure and mobility, with no abnormalities explaining vocal complaints or symptoms, confirmed by laryngeal endoscopy. Provision of written informed consent

Exclusion criteria

Exclusion criteria: Pregnant individuals. History of photosensitivity. Diagnosis of glaucoma. Dermatological treatment involving the face or neck. Use of vasodilator medications or topical acids. Presence of a cardiac pacemaker, brain pacemaker, or any other implanted electronic device. Thyroid disorders, including thyroiditis and thyroid cancer. Active malignant disease. Skin lesions, wounds, or ulcerations at the irradiation site. Human papillomavirus infection

Design outcomes

Primary

MeasureTime frame
Reduction in vocal symptoms measured by the Voice Symptom Scale (VoiSS/ESV) after photobiomodulation associated with vocal training in amateur singers with vocal symptoms. Timepoint: Baseline and after completion of the 10 intervention sessions (5 weeks).

Secondary

MeasureTime frame
Secondary Outcomes Reduction in vocal handicap in singing voice measured by the Classical Singing Handicap Index (CSHI/IDV-C). Timepoint: Baseline and after completion of the intervention protocol (5 weeks). Reduction in self-perceived vocal fatigue measured by the Vocal Fatigue Index (VFI/IFV). Timepoint: Baseline and after completion of the intervention protocol (5 weeks). Reduction in vocal effort perception measured by the Borg CR10-BR Scale adapted for vocal effort. Timepoint: Before and immediately after each intervention session. Reduction in vocal tract discomfort symptoms measured by the Vocal Tract Discomfort Scale – Brazilian Version (VTDS-BR). Timepoint: Baseline and after each intervention session. Improvement in acoustic vocal parameters obtained through sustained vowel emission, connected speech, and singing voice recordings analyzed using Voxmetria® software. Timepoint: Baseline and after each intervention session. Improvement in vocal range and vocal intensity performance assessed through Vocalgrama software during ascending and descending glissando tasks. Timepoint: Baseline and after each intervention session. Maintenance of normal laryngeal structure and mobility assessed through laryngeal endoscopy. Timepoint: Baseline assessment.

Countries

BR

Contacts

Public ContactMayara Souza

Universidade Federal de Pernambuco

maysouza94@gmail.com+55 (81) 2126-8000

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Aug 10, 2026